Exciting advancements in technology are paving the way for breakthroughs in healthcare, particularly in addressing major diseases like cancer and Alzheimer's. The biotech industry, despite recent underperformance, is poised for growth as it integrates with artificial intelligence. Meanwhile, the hedge fund landscape faces disruption from technological changes, leading to a reevaluation of risk and return strategies in a challenging economic environment.
